Skip to Content

W 15 (Pioglitazone Hydrochloride 15 mg (base))

Pill with imprint W 15 is White, Round and has been identified as Pioglitazone Hydrochloride 15 mg (base). It is supplied by Watson Laboratories, Inc..

Pioglitazone is used in the treatment of diabetes, type 2; nonalcoholic fatty liver disease and belongs to the drug class thiazolidinediones. Risk cannot be ruled out during pregnancy. Pioglitazone 15 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for W 15

Pioglitazone hydrochloride 15 mg (base) W 15
Pioglitazone hydrochloride 15 mg (base) W 15
Pioglitazone hydrochloride 15 mg (base) W 15

Pioglitazone Hydrochloride

W 15
15 mg (base)
Prescription only
Drug Class:
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Laboratories, Inc.
Inactive Ingredients:
carboxymethylcellulose calcium
hydroxypropyl cellulose (type l)
lactose monohydrate
magnesium stearate
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
68084-0878 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.